Omeros Corporation (OMER): Price and Financial Metrics
OMER Price/Volume Stats
| Current price | $10.31 | 52-week high | $13.60 |
| Prev. close | $10.24 | 52-week low | $2.61 |
| Day low | $10.08 | Volume | 2,507,400 |
| Day high | $12.83 | Avg. volume | 550,414 |
| 50-day MA | $6.93 | Dividend yield | N/A |
| 200-day MA | $4.66 | Market Cap | 597.46M |
OMER Stock Price Chart Interactive Chart >
Omeros Corporation (OMER) Company Bio
Omeros Corporation is a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded in 1994 and is based in Seattle, Washington.
OMER Price Returns
| 1-mo | 33.38% |
| 3-mo | 163.01% |
| 6-mo | 152.39% |
| 1-year | 184.02% |
| 3-year | 36.92% |
| 5-year | -32.17% |
| YTD | 215.29% |
| 2023 | 44.69% |
| 2022 | -64.85% |
| 2021 | -54.99% |
| 2020 | 1.38% |
| 2019 | 26.48% |
Continue Researching OMER
Want to see what other sources are saying about Omeros Corp's financials and stock price? Try the links below:Omeros Corp (OMER) Stock Price | Nasdaq
Omeros Corp (OMER) Stock Quote, History and News - Yahoo Finance
Omeros Corp (OMER) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...